The Use of Virtual Reality Technology During Oocyte Retrieval for in Vitro Fertilization

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-43
SponsorMount Sinai Hospital, Canada

About this trial

Ultrasound-guided oocyte retrieval (OR) is a short, but oftentimes painful procedure, during which the follicles are punctured trans-vaginally to obtain oocytes for in vitro fertilization (IVF). Conscious sedation is the most commonly used method of pain relief, yet several studies have shown that more than half of women report moderate to high levels of pain and up to 7% of women report extreme or unacceptable levels of pain during OR. Adjuvant virtual reality (VR) therapy has been explored to reduce psychological stress during dental procedures, burn wound care, colonoscopy, as well as other minor procedures. Hence, the purpose of this study is to evaluate the use of VR technology during IVF treatment, particularly with respect to tolerability, patient satisfaction, and pain reduction during oocyte retrieval.

Eligibility criteria

Qualifiers

None

Disqualifiers

severe visual impairment

severe motion sickness

epilepsy/previous seizure

claustrophobia

Trial design

Treatments tested in this trial

  • VR-based intervention (VRReliever Software V0.3.4 fromXRHealth)
  • VR headset without any scenery

Treatment groups

50 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators

Mount Sinai Hospital, Canada

Lead sponsor

University of Toronto

Sponsor institution

Reproductive Endocrinology and Infertility

Collaborator